1. Home
  2. HOWL vs TPIC Comparison

HOWL vs TPIC Comparison

Compare HOWL & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • TPIC
  • Stock Information
  • Founded
  • HOWL 2017
  • TPIC 1968
  • Country
  • HOWL United States
  • TPIC United States
  • Employees
  • HOWL N/A
  • TPIC N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • TPIC Industrial Machinery/Components
  • Sector
  • HOWL Health Care
  • TPIC Industrials
  • Exchange
  • HOWL Nasdaq
  • TPIC Nasdaq
  • Market Cap
  • HOWL 53.8M
  • TPIC 58.4M
  • IPO Year
  • HOWL 2021
  • TPIC 2016
  • Fundamental
  • Price
  • HOWL $1.21
  • TPIC $1.15
  • Analyst Decision
  • HOWL Strong Buy
  • TPIC Hold
  • Analyst Count
  • HOWL 3
  • TPIC 6
  • Target Price
  • HOWL $8.33
  • TPIC $1.82
  • AVG Volume (30 Days)
  • HOWL 490.7K
  • TPIC 616.9K
  • Earning Date
  • HOWL 08-07-2025
  • TPIC 08-07-2025
  • Dividend Yield
  • HOWL N/A
  • TPIC N/A
  • EPS Growth
  • HOWL N/A
  • TPIC N/A
  • EPS
  • HOWL N/A
  • TPIC N/A
  • Revenue
  • HOWL $1,143,000.00
  • TPIC $1,373,242,000.00
  • Revenue This Year
  • HOWL N/A
  • TPIC $10.66
  • Revenue Next Year
  • HOWL N/A
  • TPIC $6.52
  • P/E Ratio
  • HOWL N/A
  • TPIC N/A
  • Revenue Growth
  • HOWL N/A
  • TPIC 3.05
  • 52 Week Low
  • HOWL $0.60
  • TPIC $0.64
  • 52 Week High
  • HOWL $4.18
  • TPIC $5.26
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 51.44
  • TPIC 52.99
  • Support Level
  • HOWL $1.19
  • TPIC $1.06
  • Resistance Level
  • HOWL $1.35
  • TPIC $1.26
  • Average True Range (ATR)
  • HOWL 0.13
  • TPIC 0.11
  • MACD
  • HOWL -0.02
  • TPIC -0.02
  • Stochastic Oscillator
  • HOWL 21.84
  • TPIC 47.11

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About TPIC TPI Composites Inc.

TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.

Share on Social Networks: